Sona Nanotech Launches First-In-Human Trial for Gold Nanorod-Based Cancer Therapy
Sona Nanotech Inc. has announced a first-in-human clinical trial for its Targeted Hyperthermia Therapy (THT) in patients with advanced melanoma, marking a significant step in the company’s pivot into oncology and life sciences.
2 minutes to read